// App-Quantinova.ai

AB0692 (2018) : Belimumab in combination with azathioprine for remission maintenance in granulomatosis with polyangiitis and microscopic polyangiitis: effect on biomarkers

Researchers

Presenter

  • D. Jayne

Principal Investigators

  • D. Blockmans

  • R. Luqmani

  • B. Ji

  • Y. Green

  • L. Hall

  • D. Roth

  • R.B. Henderson

  • P.A. Merkel

Medical Centers

  • University of Cambridge, Cambridge, UK

  • University Hospital Gasthuisberg, Leuven, Belgium

  • Botnar Research Centre, University of Oxford, Oxford

  • GSK, Stockley Park, UK

  • GSK, Stevenage

  • GSK, Collegeville, PA

  • University of Pennsylvania, Philadelphia, PA

Locations

  • United Kingdom

  • Belgium

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Wegener's granulomatosis

  • Microscopic polyangiitis

Biomarkers

  • Cytochrome C

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Oraprine

  • Belimumab

  • Rituximab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multicenteric

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • GlaxoSmithKline (GSK)

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved